**Core Concept:**
Menorrhagia is excessive menstrual bleeding, which is a clinical presentation often seen in patients with von Willebrand's disease (vWD). vWD is a hemostatic disorder characterized by abnormal bleeding due to defects in von Willebrand factor (vWF) function or plasma vWF concentration. vWF is essential for platelet adhesion, aggregation, and the formation of a stable platelet plug during hemostasis.

**Why the Correct Answer is Right:**
In the context of the question, von Willebrand's disease is the most plausible diagnosis for the patient presenting with Menorrhagia. The coagulation profile in a patient with von Willebrand's disease will exhibit decreased vWF activity and/or vWF antigen levels. This is due to the abnormal functioning of vWF in binding to platelet glycoprotein receptors and promoting platelet adhesion and aggregation.

**Why Each Wrong Option is Incorrect:**
A) Decreased platelet count (thrombocytopenia) would lead to increased bleeding, not decreased bleeding like in von Willebrand's disease.
B) Decreased von Willebrand factor activity (option C) is more likely to be seen in type 2 von Willebrand disease, which is characterized by abnormal vWF function. In this case, we see decreased vWF activity but normal or even elevated antigen levels.
D) Increased bleeding time (option D) is a common finding in patients with von Willebrand disease, which is related to platelet function, not vWF levels or activity.

**Clinical Pearl:**
In the clinical setting, understanding the correct diagnosis (von Willebrand's disease) and the characteristic laboratory findings (decreased vWF activity and/or antigen levels) are crucial to initiate appropriate treatment and management for the patient.

**Correct Answer:**
C) Decreased von Willebrand factor activity is more likely to be seen in type 2 von Willebrand disease, which is characterized by abnormal vWF function. In this case, we see decreased vWF activity but normal or even elevated antigen levels.